13D/G large-stake feed

Latest 13D/G Reports

Since 06 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G

ARMISTICE CAPITAL, LLC stake in ARTELO BIOSCIENCES, INC.

Holder CIK 0001601086

13G ARTL
CIK
0001601086
Issuer
ARTELO BIOSCIENCES, INC.
Security
ARTL
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
10% / 235,823 shares
Filed
15 May 2026, 11:04:25 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in Voyager Therapeutics, Inc.

Holder CIK 0001601086

13G/A VYGR
CIK
0001601086
Issuer
Voyager Therapeutics, Inc.
Security
VYGR
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.9% / 3,500,000 shares
Filed
15 May 2026, 11:04:17 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in Aridis Pharmaceuticals, Inc.

Holder CIK 0001601086

13G/A ARDS
CIK
0001601086
Issuer
Aridis Pharmaceuticals, Inc.
Security
ARDS
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
11% / 5,096,251 shares
Filed
15 May 2026, 11:03:24 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

ARMISTICE CAPITAL, LLC stake in AVALON GLOBOCARE CORP.

Holder CIK 0001601086

13G ALBT
CIK
0001601086
Issuer
Avalon GloboCare Corp.
Security
ALBT
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
10% / 890,521 shares
Filed
15 May 2026, 11:02:42 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in WORKSPORT LTD.

Holder CIK 0001601086

13G/A WKSP
CIK
0001601086
Issuer
Worksport Ltd
Security
WKSP
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5% / 611,096 shares
Filed
15 May 2026, 11:02:28 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

ARMISTICE CAPITAL, LLC stake in AGIOS PHARMACEUTICALS, INC.

Holder CIK 0001601086

13G/A AGIO
CIK
0001601086
Issuer
AGIOS PHARMACEUTICALS, INC.
Security
AGIO
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
4.6% / 2,716,000 shares
Filed
15 May 2026, 11:01:59 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
1,701-1,750 of 4,060
Per page
50
Current page
35

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

11%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

ARMISTICE CAPITAL, LLC

ARTELO BIOSCIENCES, INC. (ARTL)

Schedule 13G Ownership 10% Filing-backed
CIK
000117266126002123
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
15 May 2026, 11:04:25 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G for ARTELO BIOSCIENCES, INC. (ARTL). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

Voyager Therapeutics, Inc. (VYGR)

Schedule 13G/A Ownership 5.9% Filing-backed
CIK
000117266126002122
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5.9%
Filed
15 May 2026, 11:04:17 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for Voyager Therapeutics, Inc. (VYGR). Reported class ownership: 5.9%. Ownership change: -1.3%. Share change: -12%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

Aridis Pharmaceuticals, Inc. (ARDS)

Schedule 13G/A Ownership 11% Filing-backed
CIK
000117266126002121
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
11%
Filed
15 May 2026, 11:03:24 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for Aridis Pharmaceuticals, Inc. (ARDS). Reported class ownership: 11%. Ownership change: 0%. Share change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

AVALON GLOBOCARE CORP. (ALBT)

Schedule 13G Ownership 10% Filing-backed
CIK
000117266126002120
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
10%
Filed
15 May 2026, 11:02:42 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G for AVALON GLOBOCARE CORP. (ALBT). Reported class ownership: 10%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

WORKSPORT LTD. (WKSP)

Schedule 13G/A Ownership 5% Filing-backed
CIK
000117266126002119
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5%
Filed
15 May 2026, 11:02:28 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for WORKSPORT LTD. (WKSP). Reported class ownership: 5%. Ownership change: -4.8%. Share change: -37%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

ARMISTICE CAPITAL, LLC

AGIOS PHARMACEUTICALS, INC. (AGIO)

Schedule 13G/A Ownership 4.6% Filing-backed
CIK
000117266126002118
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
4.6%
Filed
15 May 2026, 11:01:59 UTC
Period
31 Mar 2026

ARMISTICE CAPITAL, LLC filed Schedule 13G/A for AGIOS PHARMACEUTICALS, INC. (AGIO). Reported class ownership: 4.6%. Ownership change: -0.64%. Share change: -11%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
ARMISTICE CAPITAL, LLC CIK 0001601086 ARTL ARTELO BIOSCIENCES, INC. 235,823 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 VYGR Voyager Therapeutics, Inc. 3,500,000 5.9% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ARDS Aridis Pharmaceuticals, Inc. 5,096,251 11% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ALBT AVALON GLOBOCARE CORP. 890,521 10% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 WKSP WORKSPORT LTD. 611,096 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AGIO AGIOS PHARMACEUTICALS, INC. 2,716,000 4.6% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 AEMD Aethlon Medical, Inc. 82,410 5% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 WLDS Wearable Devices Ltd. 230,752 8% SEC filing
ARMISTICE CAPITAL, LLC CIK 0001601086 ADIL Adial Pharmaceuticals, Inc. 274,139 5% SEC filing
PARADIGM CAPITAL MANAGEMENT INC/NY CIK 0001037792 CRNC Cerence Inc. 2,507,276 5.6% SEC filing
Anson Funds Management LP CIK 0001491072 CJET Digital Currency X Technology Inc. 0 0% SEC filing
Solas Capital Management, LLC CIK 0001604867 FENC FENNEC PHARMACEUTICALS INC. 2,482,198 7.2% SEC filing
AQR CAPITAL MANAGEMENT LLC CIK 0001167557 RDAC Rising Dragon Acquisition Corp. 347,804 5.8% SEC filing
Caligan Partners LP CIK 0001727492 IRD Opus Genetics, Inc. 6,075,028 8.5% SEC filing
GMT CAPITAL CORP CIK 0001106191 CINT CI&T Inc 1,213,061 5.1% SEC filing
GMT CAPITAL CORP CIK 0001106191 CBRL Cracker Barrel Old Country Store, Inc. 1,590,700 7.1% SEC filing
Anson Funds Management LP CIK 0001491072 MBAV M3-BRIGADE ACQUISITION V CORP. 50,000 0.2% SEC filing
AQR CAPITAL MANAGEMENT LLC CIK 0001167557 OAKU Oak Woods Acquisition Corp 102,759 6.2% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 FVRR Fiverr International Ltd 3,045,757 8.5% SEC filing
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. CIK 0001238990 HGBL Heritage Global Inc. 2,244,148 6.5% SEC filing
GMT CAPITAL CORP CIK 0001106191 HBM Hudbay Minerals Inc. 21,904,820 5.5% SEC filing
683 Capital Management, LLC CIK 0001404574 IMUX IMMUNIC, INC. 474,200 3.4% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 MTCH Match Group, Inc. 13,271,330 5.7% SEC filing
GILDER GAGNON HOWE & CO LLC CIK 0000902464 BRCB Black Rock Coffee Bar, Inc. 602,893 3.5% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 BE Bloom Energy Corp 22,897,843 8.1% SEC filing
Caligan Partners LP CIK 0001727492 LBRX LB PHARMACEUTICALS INC 1,438,070 5% SEC filing
LMR Partners LLP CIK 0001578621 BBCQU Bleichroeder Acquisition Corp II 1,600,000 5.6% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 EVG Eaton Vance Short Duration Diversified Income Fund 1,662,358 12% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 TENB Tenable Holdings, Inc. 8,499,447 7.4% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 QTRX Quanterix Corp 3,542,374 7.5% SEC filing
Dellora Investments LP CIK 0001943462 TENX TENAX THERAPEUTICS, INC. 394,665 2.3% SEC filing
LMR Partners LLP CIK 0001578621 BZFD BuzzFeed Inc 2,444,027 6.3% SEC filing
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. CIK 0001166152 DAVA Endava plc 2,123,698 5.4% SEC filing
Caligan Partners LP CIK 0001727492 AVTX Avalo Therapeutics, Inc. 1,635,023 7.2% SEC filing
LMR Partners LLP CIK 0001578621 FGIIU FG Imperii Acquisition Corp 1,523,071 6.6% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 BUR Burford Capital Ltd 12,318,250 5.6% SEC filing
Anson Funds Management LP CIK 0001491072 EMPD Empery Digital Inc. 0 0% SEC filing
683 Capital Management, LLC CIK 0001404574 MODD Modular Medical, Inc. 259,240 4.7% SEC filing
Linonia Partnership LP CIK 0001985479 GWRE Guidewire Software, Inc. 7,651,130 9% SEC filing
LMR Partners LLP CIK 0001578621 GLEDU GalaxyEdge Acquisition Corp 980,000 6.1% SEC filing
683 Capital Management, LLC CIK 0001404574 MRSN Mersana Therapeutics, Inc. 0 0% SEC filing
683 Capital Management, LLC CIK 0001404574 GUTS FRACTYL HEALTH, INC. 7,679,615 4.8% SEC filing
Velan Capital Investment Management LP CIK 0001848809 NSPR InspireMD, Inc. 2,347,779 5% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 GCMG GCM Grosvenor Inc. 5,294,501 8.7% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 LYFT Lyft, Inc. 36,498,425 9.2% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 KTTA Pasithea Therapeutics Corp 1,350,896 5.4% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 JLS Nuveen Mortgage and Income Fund 296,505 5.4% SEC filing
LMR Partners LLP CIK 0001578621 ZKPU Lafayette Digital Acquisition Corp I 1,500,000 5.1% SEC filing
Arena Holdings Management LLC CIK 0001770583 HE HAWAIIAN ELECTRIC INDUSTRIES INC 5,119,700 3% SEC filing
AMERIPRISE FINANCIAL INC CIK 0000820027 PALI Palisade Bio, Inc. 8,711,385 5.3% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .